TATYANA GUREVICH: Open Payments
NPI 1639694680 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 26 payments from 10 companies in 2025. Trend: 2023 $664 · 2024 $326 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $323 |
| Kowa Pharmaceuticals America, Inc. | 1 | $117 |
| Aimmune Therapeutics, Inc. | 4 | $80 |
| Lundbeck LLC | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| MERZ NORTH AMERICA, INC. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: REXULTI, ZORYVE, ZENPEP, Kerendia, Xeomin, VOWST, Dexcom G6 Transmitter, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
